It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Natural killer (NK) cells are critical to both innate and adaptive immunity. However, the development and heterogeneity of human NK cells are yet to be fully defined. Using single-cell RNA-sequencing technology, here we identify distinct NK populations in human bone marrow and blood, including one population expressing higher levels of immediate early genes indicative of a homeostatic activation. Functionally matured NK cells with high expression of CX3CR1, HAVCR2 (TIM-3), and ZEB2 represents terminally differentiated status with the unique transcriptional profile. Transcriptomic and pseudotime analyses identify a transitional population between CD56bright and CD56dim NK cells. Finally, a donor with GATA2T354M mutation exhibits reduced percentage of CD56bright NK cells with altered transcriptome and elevated cell death. These data expand our understanding of the heterogeneity and development of human NK cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Laboratory of Molecular Immunology and Immunotherapy, Blood Research Institute, Versiti, Milwaukee, WI, USA; Departments of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA
2 Bioinfomatics Core, Blood Research Institute, Versiti, Milwaukee, WI, USA
3 Flow Cytometry Core, Blood Research Institute, Versiti, Milwaukee, WI, USA
4 Departments of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA
5 Departments of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
6 Departments of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA; Laboratory of Lymphocyte Biology, Blood Research Institute, Versiti, Milwaukee, WI, USA; Departments of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
7 Departments of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA; Laboratory of Stem Cell Transcriptional Regulation, Blood Research Institute, Versiti, Milwaukee, WI, USA; Departments of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA
8 Departments of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA; Laboratory of Coagulation Biology, Blood Research Institute, Versiti, Milwaukee, WI, USA
9 Laboratory of Molecular Immunology and Immunotherapy, Blood Research Institute, Versiti, Milwaukee, WI, USA; Departments of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA
10 Laboratory of Molecular Immunology and Immunotherapy, Blood Research Institute, Versiti, Milwaukee, WI, USA; Departments of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA; Departments of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA; Departments of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA